1Meittinen M, Lasota J. Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical, and molecular genetic feature and differential diagnosis [ J ]. Virchows Arch,2001,438 ( 1 ): 1-12.
2Rossi CR, Mocellin S, Mencarelli R, et al. Gastrointestinal stromal tumors: from a surgical to a molecular approach [ J ]. Int J Cancer,2003,107 (2) :171-176.
4Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor[J]. N Engl J Med,2001,344(14):1052-1056.
5Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J]. N Engl J Med,2002,347(7) :472-480.
6Ng EH, Pollock RE, Munsell MF, et al. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging [ J ]. Ann Surg, 1992,215( 1 ) :68-77.
7DeMatteo R, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival[J]. Ann Surg,2000,231 ( 1 ) :51-58.
10Roberts PJ, Eisenberg B. Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease [ J ]. European J Cancer,2002,38suppl 5 :s37-s38.
二级参考文献18
1Mazur MT,Clark HB.Gastric stromal tumors:reappraisal of histogenesis. Am J Surg Pathol, 1983, 7: 507-519.
2Meittinen M, Lasola J. Gastrointestinal stromal tumors-definition,clinical, histological, immunohistochemical, and differential diagnosis. Virchows Arch, 2001, 438: 1-12.
3DeMatteo R, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg, 2000, 231: 51-58.
4Ng EH, Pollock RE, Munsell MF, et al. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Ann Surg,1992,215: 68-77.
5Crosby JA, Catton LN, Davis A, et al. Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database. Ann Surg Oncol, 2001, 8: 50-59.
6Taniguchi N, Nishida T, Hirota S, et al. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Bes, 1999, 59:4297-4300.
7Clary BM, DeMatteo BP, Lewis ,I,I, et al. Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and restroperitomeum:a clinical comparison. Ann Surg Oneol, 2001, 8: 290-299.
8Muan SS, Conlon KC, Woodruff JM, et al. Salvage surgery for patients with recurrent gastrointestinal sarcoma: prognostic factors to guide patient selection. Cancer, 2000, 88: 66-74.
9Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med, 2002, 347: 472-480.
10Emory TS, Sobin LH, Lukes L, et al. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol, 1999,23:82-87.
